Company profile
Pionyr Immunotherapeutics company profile
Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity. The company is exploiting novel target discovery and antibody generation platform technologies to create the next generation of immuno-oncology therapeutics. The company’s approach, Myeloid Tuning™, is designed to enhance the immune system’s anti-tumor response by altering the cellular infiltrate of the tumor microenvironment with high specificity.
Business identity
- Website
- http://www.pionyrtx.com/
- Contact email
- [email protected]
- Phone number
- (415)226-7503
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $0-$1M
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- South San Francisco, California, United States
- Postal code
- 94080
- Country code
- US
- Continent
- North America